Roberta Costi - Concepedia

Author

Roberta Costi

Istituto Pasteur ORCID

Also Known As

COSTI, Roberta, Costi, R, Costi, R., Costi, Roberta, R Costi, R. COSTI, R. Costi, Renato Costi, Roberta Costi

183

Publications

Citations

H-Index

Concepts

All Affiliations

Istituto Pasteur Sapienza University of Rome Istituto Superiore di Sanità University of Cagliari University of Siena

About

Roberta Costi is an author at Istituto Pasteur specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	48	1.8K
2	Biochemistry	22	29	1.2K
3	Natural Sciences	20	27	1.2K
4	Engineering	6	6	109
5	Education	1	1	27

Roberta Costi

106

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Geometrically and Conformationally Restrained Cinnamoyl Compounds as Inhibitors of HIV-1 Integrase: Synthesis, Biological Evaluation, and Molecular Modeling Marino Artico, Roberto Di Santo, Roberta Costi, Journal of Medicinal Chemistry Combinatorial ChemistryHiv-1 IntegraseEnzyme AssaysBioorganic ChemistryAntiviral Drug	1998	162
Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies Rino Ragno, Garland R. Marshall, Roberto Di Santo, Bioorganic & Medicinal Chemistry	2000	132
6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro Enzo Tramontano, Francesca Esposito, Roberta Badas, Antiviral Research Medicinal ChemistryViral ReplicationHiv-1 Viral ReplicationMedicineNatural Sciences	2005	117
Antifungal Agents. 11.<i>N</i>-Substituted Derivatives of 1-[(Aryl)(4-aryl-1<i>H</i>-pyrrol-3-yl)methyl]-1<i>H</i>-imidazole: Synthesis, Anti-<i>Candida</i>Activity, and QSAR Studies Roberto Di Santo, Andrea Tafi, Roberta Costi, Journal of Medicinal Chemistry	2005	116
Novel Bifunctional Quinolonyl Diketo Acid Derivatives as HIV-1 Integrase Inhibitors: Design, Synthesis, Biological Activities, and Mechanism of Action Roberto Di Santo, Roberta Costi, Alessandra Roux, Journal of Medicinal Chemistry Hiv-1 IntegraseEncoded Integrase ProteinBiological ActivitiesAntiviral DrugChemical Biology	2006	85
2,6-Bis(3,4,5-trihydroxybenzylydene) derivatives of cyclohexanone Roberta Costi, Roberto Di Santo, Marino Artico, Bioorganic & Medicinal Chemistry HeterocyclicDerivativesOrganic ChemistryChemistryDerivative (Chemistry)	2003	81
Novel 3,5-Bis(bromohydroxybenzylidene)piperidin-4-ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular Activity Donghang Cheng, Sérgio Valente, Sabrina Castellano, Journal of Medicinal Chemistry Drug TargetChemoprevention StrategyPsa Promoter ActivityChemical BiologyCancer Biology	2011	81
Activity of caffeic acid derivatives against Candida albicans biofilm Daniela De Vita, Laura Friggeri, Felicia Diodata D’Auria, Bioorganic & Medicinal Chemistry Letters Antifungal AgentMicrobiologyAntimicrobial CompoundMedicineCaffeic Acid Derivatives	2014	74
Structure–Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain Giuliana Cuzzucoli Crucitti, Mathieu Métifiot, Luca Pescatori, Journal of Medicinal Chemistry Structure–activity RelationshipHiv-1 IntegraseMolecular BiologyAntiviral DrugMedicinal Chemistry	2015	73
Antifungal Agents. 10. New Derivatives of 1-[(Aryl)[4-aryl-1<i>H</i>-pyrrol-3-yl]methyl]-1<i>H</i>-imidazole, Synthesis, Anti-<i>Candida</i> Activity, and Quantitative Structure−Analysis Relationship Studies Andrea Tafi, Roberta Costi, Maurizio Botta, Journal of Medicinal Chemistry	2002	72

Page 1